home / United States / Anavex Life Sciences

Anavex Life Sciences Market Cap

$0.78 B

+25.52 M

NASDAQ:AVXL · April 16, 2025

Share price

$9.12

Enterprise Value

$0.63 B

Change (1-Year)

116.5%

Global Rank

#5387

Country Rank

#1974

Regions

USA

Market cap

As of April 16, 2025, Anavex Life Sciences (AVXL) has a market cap of $0.78 billion USD. According to our data, Anavex Life Sciences is ranked No.5387 in global market value.

Sector Rank:

Biotech #282 Pharmaceuticals #258 Genomics #14

AVXL Market Capitalization Growth

1 Years Growth:

116.5%

3 Years Growth:

-16.2%

5 Years Growth:

172.8%

10 Years Growth:

567.4%

15 Years Growth:

-22.2%

20 Years Growth:

10.1%

Total Growth:

11%

Anavex Life Sciences Market Cap Chart

YTD

10Y

15Y

20Y

MAX

Anavex Life Sciences Market Cap CAGR Chart

Anavex Life Sciences Market Cap History 2006 - 2025

Year	Market Cap	%Change
Apr 16, 2025	$0.78 B	-14.83%
Dec 31, 2024	$0.91 B	15.36%
Dec 29, 2023	$0.79 B	0.54%
Dec 30, 2022	$0.79 B	-46.60%
Dec 31, 2021	$1.47 B	221.11%
Dec 31, 2020	$0.46 B	108.49%
Dec 31, 2019	$0.22 B	66.03%
Dec 31, 2018	$0.13 B	-51.55%
Dec 29, 2017	$0.27 B	-18.69%
Dec 30, 2016	$0.34 B	-28.90%
Dec 31, 2015	$0.47 B	652.70%
Dec 31, 2014	$62.76 M	-26.00%
Dec 31, 2013	$84.82 M	-68.35%
Dec 31, 2012	$0.27 B	-35.25%
Dec 30, 2011	$0.41 B	-66.58%
Dec 31, 2010	$1.24 B	69.77%
Dec 31, 2009	$0.73 B	-17.31%
Dec 31, 2008	$0.88 B	-50.48%
Dec 31, 2007	$1.78 B	94.44%
Dec 29, 2006	$0.92 B	100%

Similar Companies to Anavex Life Sciences

Name	Market Cap	Market cap difference	Regions
Biogen BIIB	$17.12 B	0.000 M	USA
Eli Lilly LLY	$679.94 B	-0.022 M	USA
Novartis NVS	$217.12 B	0.003 M	Switzerland
Pfizer PFE	$127.27 B	-0.003 M	USA
Merck MRK	$197.26 B	0.003 M	USA
Johnson & Johnson JNJ	$370.20 B	0.003 M	USA
AbbVie ABBV	$312.76 B	-0.013 M	USA
Amgen AMGN	$158.77 B	0.132 B	USA
Bristol-Myers Squibb BMY	$101.74 B	-0.001 M	USA
Sanofi SNY	$123.58 B	-0.002 M	France
GlaxoSmithKline GSK	$72.33 B	-0.002 M	UK
AstraZeneca AZN	$210.42 B	-0.005 M	UK
Teva Pharmaceutical Industries TEVA	$15.60 B	0.000 M	Israel
Regeneron Pharmaceuticals REGN	$60.99 B	1.014 B	USA

About Anavex Life Sciences Inc.

Name

Anavex Life Sciences Corp.

Website

https://www.anavex.com

Headquarters

New York,NY

symbol

AVXL

CURRENCY

USD

country

United States

fullTimeEmployees

exchange

NMS

firstTradeDateEpochUtc

1969/12/31

AVXL Market Cap Formula

Market Cap	=	AVXL Stock Price	*	AVXL Shares Outstanding
	=	$9.12	*	85.06 M
	=	$0.78 B

What is Market Cap?

Market capitalization represents the market's valuation of a company, calculated by multiplying the current share price by the total number of outstanding shares. It helps to assess the company's size and allows for comparison with other companies.

Material

wikipedia Share_price outstanding

What is Market Capitalization?

Market capitalization, or market cap, is a key measure of a company's market value. It is calculated by multiplying the current stock price by the total number of outstanding shares. Market cap is often used by investors to assess a company's size, stability, and market presence. For any inquiries or to report an issue, please email us at [email protected].

Disclaimer

This website provides general information only. While we aim for accuracy, we do not guarantee data completeness or reliability. Consult a financial advisor before investing. We are not responsible for any losses or damages from using this site. By using it, you agree to these terms. Company logos belong to their respective copyright holders and are shown for editorial purposes only. Prices are not in real time.

America

Europe